Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-22-034073
Filing Date
2022-12-01
Accepted
2022-12-01 07:00:23
Documents
3
Period of Report
2022-12-01

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 23256
2 ex99-1.htm EX-99.1 18233
3 ex99-1_001.jpg GRAPHIC 5371
  Complete submission text file 0001493152-22-034073.txt   49928
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41386 | Film No.: 221437275
SIC: 2836 Biological Products, (No Diagnostic Substances)